Pfizer and Array BioPharma
Pfizer is shelling out almost $11 billion for Array BioPharma, a company that specializes in cancer treatment. Pfizer is already strong in breast and prostate cancer treatment, but the Array buy gives it a boost in treating colorectal cancer in particular. Wall Street...